Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 17.9B | 19.4B | 20.6B | 23.1B |
Cost of revenue | 11.0B | 14.4B | 15.3B | 19.2B |
Gross profit | 6.9B | 5.0B | 5.3B | 3.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 18M | 20M | 20M | 19M |
Operating income | 4.5B | 5.0B | 5.3B | 3.9B |
Non operating interest income | ||||
Income | 188M | — | — | 21M |
Expense | 4.3B | 4.0B | 4.3B | 4.2B |
Other income expense | 283M | -673M | 729M | 316M |
Pretax income | 598M | 360M | 1.7B | 19M |
Tax provision | 383M | 259M | 138M | 304M |
Net income | 215M | 101M | 1.5B | -285M |
Basic EPS | 0.0 | 0.3 | 0.0 | 0.0 |
Diluted EPS | 0.0 | 0.3 | 0.0 | 0.0 |
Basic average shares | 1.1B | 1.1B | 1.1B | 1.1B |
Diluted average shares | 1.1B | 1.1B | 1.1B | 1.1B |
EBITDA | 8.2B | 8.4B | 8.5B | 7.2B |
Net income from continuing op. | — | 101M | 1.5B | -285M |
Minority interests | -142M | 331M | -1.5B | 328M |
Preferred stock dividends | — | — | — | — |